Protara Therapeutics Inc (TARA)

Protara Therapeutics Inc (TARA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $137M; returns 1 day -4.5%, 1 week +0.4%, 1 year -54.8%.

Protara Therapeutics Inc. (NASDAQ: TARA) is a clinical-stage biopharmaceutical company focused on developing transformative therapies for cancer and rare diseases. Their lead program is TARA-002, an investigational cell therapy being evaluated in Phase II clinical trials for non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs).

Groups TARA belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Oncology
• Rare Diseases
• Lymphatic Malformations
• Healthcare
• Clinical Stage
• Liver Disease
• Fast Track Designation

TARA financial model: income statement, cash flow and balance sheet